Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia

Table 1

Markers of bone resorption after and before zoledronic i.v. administrations.

	Urinary deoxypyridinoline (U-DPD) nmol/mmol	Sieric carboxyterminal cross-linked telopeptide of type I collagen (S-ICTP) pg/mL
Before the first zoledronic infusion	24,6	1549
After the first zoledronic infusion	17,22	1033
Before the second zoledronic infusion	33,2	2096
After the second zoledronic infusion	22	1362,4